INTERFERON SIGNALING THROUGH ARACHIDONIC-ACID DEPENDENT PATHWAYS - A CLUE TO ADJUVANT THERAPY FOR CHRONIC VIRAL-HEPATITIS

被引:17
作者
BASKIN, G
机构
[1] Uthsc-San Antonio, San Antonio, Texas
关键词
D O I
10.1002/hep.1840140229
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Molecular mechanisms that mediate signal transduction by growth inhibitory cytokines are poorly understood. Type I (α and β) interferons (IFNs) are potent growth inhibitory cytokines whose biological activities depend on induced changes in gene expression. IFN‐α induced transient activation of phospholipase A2 in 3T3 fibroblasts and rapid hydrolysis of [3H]‐arachidonic acid (AA) from prelabeled phospholipid pools. The phospholipase inhibitor, bromophenacyl bromide (BPB), specifically blocked IFN‐induced binding of nuclear factors to a conserved, IFN‐regulated enhancer element, the interferonstimulated response element (ISRE). BPB also caused a dose‐dependent inhibition of IFN‐α‐stimulated ISRE‐dependent transcription in transient transfection assays. Specific inhibition of AA oxidation by eicosatetraynoic acid prevented IFN‐α induction of factors binding to ISRE. Treatment of intact cells with inhibitors of fatty acid cyclooxygenase or lipoxygenase enzymes resulted in amplification of IFN‐α‐induced ISRE binding and gene expression. Thus, IFN‐α receptor‐coupled AA hydrolysis may function in activation of latent factors by IFN‐α and provides a system for studying the role of AA metabolism in transduction of growth inhibitory signals. Copyright © 1991 American Association for the Study of Liver Diseases
引用
收藏
页码:392 / 394
页数:3
相关论文
共 14 条
[1]  
CERINI R, 1990, HEPATOLOGY, V12, P961
[2]   TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALFA - A MULTICENTER RANDOMIZED, CONTROLLED TRIAL [J].
DAVIS, GL ;
BALART, LA ;
SCHIFF, ER ;
LINDSAY, K ;
BODENHEIMER, HC ;
PERRILLO, RP ;
CAREY, W ;
JACOBSON, IM ;
PAYNE, J ;
DIENSTAG, JL ;
VANTHIEL, DH ;
TAMBURRO, C ;
LEFKOWITCH, J ;
ALBRECHT, J ;
MESCHIEVITZ, C ;
ORTEGO, TJ ;
GIBAS, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1501-1506
[3]   PILOT-STUDY OF RECOMBINANT HUMAN ALPHA-INTERFERON FOR CHRONIC TYPE-B HEPATITIS [J].
DOOLEY, JS ;
DAVIS, GL ;
PETERS, M ;
WAGGONER, JG ;
GOODMAN, Z ;
HOOFNAGLE, JH .
GASTROENTEROLOGY, 1986, 90 (01) :150-157
[4]   INTERFERON-GAMMA PRODUCTION BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF PATIENTS WITH CHRONIC LIVER-DISEASE [J].
FUJI, A ;
KAKUMU, S ;
OHTANI, Y ;
MURASE, K ;
HIROFUJI, H ;
TAHARA, H .
HEPATOLOGY, 1987, 7 (03) :577-581
[5]   SIGNAL TRANSDUCTION BY INTERFERON-ALPHA THROUGH ARACHIDONIC-ACID METABOLISM [J].
HANNIGAN, GE ;
WILLIAMS, BRG .
SCIENCE, 1991, 251 (4990) :204-207
[6]   RANDOMIZED, CONTROLLED TRIAL OF RECOMBINANT HUMAN ALPHA-INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS-B [J].
HOOFNAGLE, JH ;
PETERS, M ;
MULLEN, KD ;
JONES, DB ;
RUSTGI, V ;
DIBISCEGLIE, A ;
HALLAHAN, C ;
PARK, Y ;
MESCHIEVITZ, C ;
JONES, EA .
GASTROENTEROLOGY, 1988, 95 (05) :1318-1325
[7]   EVIDENCE FOR A DEFICIENCY OF INTERFERON-PRODUCTION IN PATIENTS WITH CHRONIC HEPATITIS-B VIRUS-INFECTION ACQUIRED IN ADULT LIFE [J].
IKEDA, T ;
LEVER, AML ;
THOMAS, HC .
HEPATOLOGY, 1986, 6 (05) :962-965
[8]   INTERFERON-PRODUCTION BY PERIPHERAL LYMPHOCYTES IN HBSAG-POSITIVE LIVER-DISEASES [J].
KATO, Y ;
NAKAGAWA, H ;
KOBAYASHI, K ;
HATTORI, N ;
HATANO, K .
HEPATOLOGY, 1982, 2 (06) :789-790
[9]  
LISKERMELMAN M, 1988, GASTROENTEROLOGY, V94, pA564
[10]   INTERFERON ANTIBODIES MAY NEGATE THE ANTIVIRAL EFFECTS OF RECOMBINANT ALPHA-INTERFERON TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS-B VIRUS-INFECTION [J].
LOK, ASF ;
LAI, CL ;
LEUNG, EKY .
HEPATOLOGY, 1990, 12 (06) :1266-1270